From Pandemic Urgency to Practical Impact: How Diagnostics Investment Priorities Are Evolving
Speed still matters, but there’s been a shift in the industry. It’s not enough to be scientifically sound. Now, practicality is of utmost importance.
Jamie Platt
Dr. Jamie Platt is CEO of Pictor and has more than 20 years of experience in genomics and molecular diagnostics. She has led the development and commercialization of high-complexity diagnostic tests globally and serves on the boards of DxTerity and bioAffinity Technologies. Jamie is a recognized voice in the diagnostics field, focused on advancing clinically meaningful, accessible testing that delivers real-world value for laboratories and health systems.